logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9314497 B1

PDFFull Text
Expired
Date of Patent:
Apr. 19, 2016

Filed:

Sep. 02, 2014

E2f as a target of hormone refractory prostate cancer

Applicant:

Rutgers, the State University of New Jersey, New Brunswick, NJ (US);

Inventors:

Joseph R. Bertino, Brantford, CT (US);

Debabrata Banerjee, Bellerose, NY (US);

Tamara Minko, Edison, NJ (US);

Olga B. Garbuzenko, Highland Park, NJ (US);

Xiaoqi Xie, Lawrenceville, NJ (US);

John E. Kerrigan, East Windsor, NJ (US);

Emine E. Abali, Tenafly, NJ (US);

Kathleen W. Scotto, Washington Crossing, PA (US);

Assignee:

RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, New Brunswick, NJ (US);

Attorney:

Fox Rothschild LLP

Primary Examiner:

Thomas S Heard

Int. Cl.
CPC ...
A61K 38/08 (2006.01); A61K 9/127 (2006.01); A61K 38/16 (2006.01); A61K 31/4436 (2006.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01); A61K 45/06 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 9/1271 (2013.01); A61K 31/4436 (2013.01); A61K 31/513 (2013.01); A61K 31/519 (2013.01); A61K 38/16 (2013.01); A61K 45/06 (2013.01); C07K 14/4703 (2013.01);
Abstract

The instant invention provides amino acid sequences competing with E2F for DNA binding. Methods of using said amino acid sequences for treatment of hormone-refractory prostate cancer are also provided.

Find Patent Forward Citations

Bertino, Joseph. (2016). E2f as a target of hormone refractory prostate cancer (U.S. Patent No. 9314497). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9314497

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…